ROXILOX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Roxilox, and when can generic versions of Roxilox launch?
Roxilox is a drug marketed by Roxane and is included in one NDA.
The generic ingredient in ROXILOX is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
Summary for ROXILOX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 99 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ROXILOX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ROXILOX
US Patents and Regulatory Information for ROXILOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roxane | ROXILOX | acetaminophen; oxycodone hydrochloride | CAPSULE;ORAL | 040061-001 | Jul 3, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |